Seronegative spondarthritides.
We have attempted to review the epidemiology of a group of diseases collectively termed the seronegative spondarthritides. In discussing environmental influences on these diseases we have reviewed shared aetiological hypotheses and how these have been, and may be, manipulated to influence disease development. The socioeconomic impact of disease has been discussed, together with some of the strategies we might adopt to prevent further disability and handicap. Recent developments, particularly in the laboratory, promise imminent advances in the aetiopathogenesis of this group of chronic inflammatory disorders.
Helliwell
P
P
Wright
V
V
D000906:Antibodies / Q000032:analysis*; D001168:Arthritis / Q000209:etiology / Q000235:genetics / Q000276:immunology*; D016918:Arthritis, Reactive / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology; D001528:Behcet Syndrome / Q000453:epidemiology / Q000503:physiopathology; D004777:Environment; D006680:HLA Antigens / Q000032:analysis / Q000145:classification; D006801:Humans; D011565:Psoriasis / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology; D013122:Spinal Diseases / Q000209:etiology / Q000235:genetics / Q000276:immunology*; D013167:Spondylitis, Ankylosing / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D014481:United States
D000906:Antibodies; D006680:HLA Antigens